1 / 14

ME/CFS Society (SA) Inc. Annual Awareness Day Seminar Wednesday 12 th May 2004

ME/CFS Society (SA) Inc. Annual Awareness Day Seminar Wednesday 12 th May 2004. Dr Peter Del Fante Medical Director Adelaide Western Division Of General Practice. Outline of Presentation. ME/CFS Definition Debate ME/CFS SA GP Guidelines ME/CFS Research & Funding ME/CFS UK Developments

uta
Télécharger la présentation

ME/CFS Society (SA) Inc. Annual Awareness Day Seminar Wednesday 12 th May 2004

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. ME/CFS Society (SA) Inc.Annual Awareness Day SeminarWednesday 12th May 2004 Dr Peter Del Fante Medical Director Adelaide Western Division Of General Practice

  2. Outline of Presentation • ME/CFS Definition Debate • ME/CFS SA GP Guidelines • ME/CFS Research & Funding • ME/CFS UK Developments • ME/CFS Adelaide Network • ME/CFS Future Directions

  3. ME/CFS Definition Debate • ME/CFS is now a recognised medical condition – worldwide consensus • However, there is still significant tension between psychological and biological models of ME/CFS • Controversial Fatigue Syndrome • New Canadian Definition to the rescue

  4. ME/CFS Definition Debate • Most CFS case definitions or diagnostic criteria have been developed for research purposes only and not clinical use. • The most widely used research case definition for ME/CFS is the one developed by Fukuda (1994) at the US Centers for Disease Control – vague / overinclusive. • New Canadian criteria (2003) better reflects the clinical aspects of ME/CFS.

  5. Canadian ME/CFS Clinical Case Definition - 2003 • Chronic Fatigue (>6 months) • Post-exertional malaise (> 24 hours) • Sleep dysfunction • Pain (joint, muscle & headache) • Neuro-cognitive manifestations • Poor concentration/memory; impaired information processing   • Other manifestations: • Neuroendocrine manifestations: • sweating episodes; cold extremities; intolerance of extremes of hot and cold; marked weight change; etc • Autonomic manifestations: • Low BP; high HR; light headedness; Irritable bowel • Immune Manifestations: • tender lymph nodes; recurrent sore throats; recurrent flu-like symptoms; general malaise; new sensitivities to foods, medications and / or chemicals Exclusion criteria: extensive list, including primary psychiatric disorders

  6. ME/CFS GP Guidelines • ME/CFS is considered to be a complex, multi-system, and multi-causal illness. • Not easy to develop consensus guidelines • Requires a genuine collaborative effort • Patients, ME/CFS Society, SA Dept for Human Services, GPs, Clinicians, Psychiatrists, Researchers and Academics. • Utilise the new Canadian criteria • ME/CFS GP Guidelines are a South Australian first that will not be kept a secret.

  7. ME/CFS GP Guidelines • They will help ensure better basic care of ME/CFS patients by GPs, especially in rural areas. • They aim to optimise all aspects of care that can contribute to partial or full recovery. • Dynamic guidelines that will be updated regularly with new knowledge. • Links with future Fibromyalgia and Multiple Chemical Sensitivity guidelines.

  8. ME/CFS Research & Funding • In Australia, research into ME/CFS is minimal when compared to UK and USA, and is mostly dominated by proponents of psychological models and treatments. • Research funding bias towards psychological models (CBT) or graded exercise therapy. • In reality, like every other medical illness or disease, it is best to have a bio-psycho-social approach to the understanding and treatment of ME/CFS.

  9. ME/CFS UK Developments • UK Action for ME guidelines sent to all GPs via NHS. • PACE study (Dr Peter White, London) • Pacing, Activity and Cognitive behaviour therapy : a randomised control Evaluation • Pacing – Adaptive Pacing Therapy • Activity – Graded Exercise Therapy • FINE study (Dr Alison Weardon, Manchester) • Fatigue Intervention by Nurses Evaluation • Home visiting service for severe CFS.

  10. ME/CFS UK Developments • Estimated 240000 UK sufferers with CFS • Cost to economy has been estimated at: • Total : A$8.8 billion per annum • A$5.5 billion pa on social security alone • Annual medical costs A$525 million pa. • UK Nationwide ME/CFS Treatment Centres • 12 new dedicated centres – cost A$21million • Multidisciplinary Care Teams (Doctors, OTs, etc) • Support development & integration of local services and GPs + professional training

  11. ME/CFS Adelaide Clinical & Research Network • Collaborative approach between patients, the ME/CFS Society (SA), clinicians and researchers. • Regular forums to discuss progress with research and treatments • Encourage and support new research and clinical initiatives in SA • Development of user-friendly healthcare provider treatment and patient self-management guidelines • Continuing professional education / seminars

  12. ME/CFS Adelaide Clinical & Research Network • New research into Rickettsia and CFS • Creation of an ME/CFS patient register for: • Longitudinal study of ME/CFS outcomes / prognosis • Cohorts for clinical and basic research • Linking of research and clinical findings within the patient database • A referral centre for multidisciplinary assessment, management and support for more severe ME/CFS patients. • Funding to date: • $5000 PHCRED; $5000 DHS.

  13. ME/CFS Future Directions • Promote community awareness and professional recognition that ME/CFS is a complex and severely debilitating illness in our society that deserves government support • Research must focus on ‘real’ ME/CFS patients that meet the Canadian criteria (or similar) if we are to truly advance our understanding and management of ME/CFS • Funding must be provided for both research and treatment of all aspects of this condition within the context of a balanced bio-psycho-social model.

  14. “A physician who does not admit to the reality of a disease cannot be supposed to cure it.” William Cullen (1710-90)

More Related